Capitalization 15.02B 1.39B 108B P/E ratio 2024 *
55.4x
P/E ratio 2025 * 41.6x
Enterprise value 10.36B 961M 74.41B EV / Sales 2024 *
6.78x
EV / Sales 2025 * 6.04x
Free-Float
99.6%
Yield 2024 *
0.96%
Yield 2025 * 1.12%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.44%
1 week-1.91%
Current month+16.62%
1 month+16.62%
3 months+18.36%
6 months+36.83%
Current year+42.26%
More quotes
1 week
179.00
Extreme 179
197.50
1 month
154.50
Extreme 154.5
197.90
Current year
122.20
Extreme 122.2
197.90
1 year
83.05
Extreme 83.05
197.90
3 years
83.05
Extreme 83.05
295.60
5 years
78.05
Extreme 78.05
295.60
10 years
9.80
Extreme 9.8
295.60
More quotes
Insider TitleAgeSince
Chief Executive Officer 72 08/02/06
Director of Finance/CFO 56 24/09/23
Chief Tech/Sci/R&D Officer 54 -
Insider TitleAgeSince
Director/Board Member 69 -
Director/Board Member 62 23/04/19
Director/Board Member 62 31/10/19
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.32%-1.91%+42.47%-18.86% 1.39B
-0.66%-11.08%-39.63%-56.21% 15.12B
+4.41%+8.17%-57.55%-75.41% 2.47B
-4.29%-5.76%+118.78%+149.06% 1.7B
-3.32%+2.74%+28.31% - 1.43B
-3.58%+8.12%-22.83% - 862M
-0.76%-0.97%-8.42%-56.55% 837M
+1.39%-3.25%-37.20%-45.41% 595M
+1.55%-11.72%+4.56%-42.32% 536M
-0.16%-1.60%+24.50%-17.59% 294M
Average -0.77%-0.88%+5.30%-20.41% 2.52B
Weighted average by Cap. -1.46%-4.81%-18.95%-39.68%
See all sector performances

Financials

Ratios2024 *2025 *
Net sales 2.18B 202M 15.64B 2.42B 224M 17.35B
Net income 272M 25.19M 1.95B 363M 33.66M 2.61B
Net Debt -250M -23.18M -1.8B -431M -39.99M -3.1B
More financial data * Estimated data
Logo Biotage AB
Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company’s offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.
Employees
667
Calendar
More about the company
Date Price Change Volume
24/07/24 189.10 kr +0.75% 11 819
23/07/24 187.70 kr -0.69% 31,724
22/07/24 189.00 kr +2.00% 70,273
19/07/24 185.30 kr -2.52% 158,720
18/07/24 190.10 kr -1.96% 93,068

Delayed Quote Nasdaq Stockholm, July 24, 2024 at 11:06 am

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
187.70SEK
Average target price
191.00SEK
Spread / Average Target
+1.76%
Consensus